Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer

doi:10.3748/wjg.v19.i18.2731

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7208)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

486

HTML

4049

Figures (1-1)

285

Tables (1-1)

269

Sum=5089

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1152

Download

967

Sum=2119

May 14, 2013 (publication date) through Jan 6, 2025

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Gastroenterol. May 14, 2013; 19(18): 2731-2735
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2731

Full Size Figure Download Figure

Figure 1 The possible signal pathway activated by cathelicidin (LL-37) to inhibit cell proliferation in gastric cancer cells. BMPR: Bone morphogenetic protein.

Citation: Chow JYC, Li ZJ, Kei WK, Cho CH. Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer. World J Gastroenterol 2013; 19(18): 2731-2735
URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2731.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2731